

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.70102550 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.70102550 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.70102550 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.70102550 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.70102550 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.70102550 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.54811648 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.41041002 |
| 9 | microglial cell activation (GO:0001774) | 5.19196788 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.45814392 |
| 11 | response to host immune response (GO:0052572) | 4.40914136 |
| 12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.40914136 |
| 13 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.25517946 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.19012580 |
| 15 | response to host (GO:0075136) | 4.06450419 |
| 16 | response to host defenses (GO:0052200) | 4.06450419 |
| 17 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.06450419 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.94158406 |
| 19 | macrophage activation (GO:0042116) | 3.81900444 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.77934622 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.77934622 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 3.70595271 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.67435189 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.67053233 |
| 25 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.61778564 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 3.49985082 |
| 27 | myeloid cell activation involved in immune response (GO:0002275) | 3.48580643 |
| 28 | response to peptidoglycan (GO:0032494) | 3.47526623 |
| 29 | detection of other organism (GO:0098543) | 3.43793632 |
| 30 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.30456834 |
| 31 | L-amino acid import (GO:0043092) | 3.29478656 |
| 32 | I-kappaB phosphorylation (GO:0007252) | 3.27372188 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.24380361 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21218543 |
| 35 | synaptic vesicle maturation (GO:0016188) | 3.20143399 |
| 36 | detection of bacterium (GO:0016045) | 3.13831496 |
| 37 | respiratory burst (GO:0045730) | 3.10634990 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.10307949 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.09244484 |
| 40 | negative regulation of interleukin-17 production (GO:0032700) | 3.04069180 |
| 41 | protein localization to endosome (GO:0036010) | 3.02840704 |
| 42 | positive regulation of mast cell activation (GO:0033005) | 2.99681087 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92881391 |
| 44 | germinal center formation (GO:0002467) | 2.92789959 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 2.90138796 |
| 46 | apoptotic cell clearance (GO:0043277) | 2.89880720 |
| 47 | regulation of leukocyte degranulation (GO:0043300) | 2.89258128 |
| 48 | detection of biotic stimulus (GO:0009595) | 2.86321165 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85690233 |
| 50 | phagosome maturation (GO:0090382) | 2.83767884 |
| 51 | mannose metabolic process (GO:0006013) | 2.81912796 |
| 52 | granulocyte activation (GO:0036230) | 2.81718562 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81265869 |
| 54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80673910 |
| 55 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77792412 |
| 56 | locomotory exploration behavior (GO:0035641) | 2.77508393 |
| 57 | regulation of macrophage cytokine production (GO:0010935) | 2.77485238 |
| 58 | positive regulation of mast cell degranulation (GO:0043306) | 2.76130156 |
| 59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76130156 |
| 60 | regulation of regulated secretory pathway (GO:1903305) | 2.75794735 |
| 61 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75621084 |
| 62 | neutrophil activation (GO:0042119) | 2.74896472 |
| 63 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.73344079 |
| 64 | regulation of beta-amyloid formation (GO:1902003) | 2.72283796 |
| 65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70370918 |
| 66 | amino acid import (GO:0043090) | 2.69826354 |
| 67 | cellular potassium ion homeostasis (GO:0030007) | 2.69104078 |
| 68 | regulation of ARF protein signal transduction (GO:0032012) | 2.68906936 |
| 69 | T-helper 1 type immune response (GO:0042088) | 2.68075888 |
| 70 | response to muramyl dipeptide (GO:0032495) | 2.67609542 |
| 71 | leukocyte aggregation (GO:0070486) | 2.66844443 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66527924 |
| 73 | regulation of cellular amide metabolic process (GO:0034248) | 2.63663882 |
| 74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.63386507 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63197971 |
| 76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.61905195 |
| 77 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.61706814 |
| 78 | positive regulation of leukocyte degranulation (GO:0043302) | 2.60674474 |
| 79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60502444 |
| 80 | positive regulation of type 2 immune response (GO:0002830) | 2.60001017 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.59470946 |
| 82 | regulation of mast cell activation (GO:0033003) | 2.58711834 |
| 83 | regulation of gamma-delta T cell activation (GO:0046643) | 2.57881398 |
| 84 | regulation of type 2 immune response (GO:0002828) | 2.57498969 |
| 85 | sodium ion export (GO:0071436) | 2.57094126 |
| 86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.55758925 |
| 87 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.54735456 |
| 88 | positive regulation of macrophage cytokine production (GO:0060907) | 2.53945272 |
| 89 | positive regulation of regulated secretory pathway (GO:1903307) | 2.53062091 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52994869 |
| 91 | regulation of macrophage chemotaxis (GO:0010758) | 2.52803440 |
| 92 | alanine transport (GO:0032328) | 2.52503919 |
| 93 | amino sugar catabolic process (GO:0046348) | 2.52419415 |
| 94 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.51335755 |
| 95 | negative regulation of type 2 immune response (GO:0002829) | 2.50406068 |
| 96 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.50256233 |
| 97 | barbed-end actin filament capping (GO:0051016) | 2.49758601 |
| 98 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49522994 |
| 99 | negative regulation of interleukin-6 production (GO:0032715) | 2.47817644 |
| 100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.47740183 |
| 101 | regulation of synapse structural plasticity (GO:0051823) | 2.46036727 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.44528910 |
| 103 | neutrophil chemotaxis (GO:0030593) | 2.44407572 |
| 104 | synaptic vesicle exocytosis (GO:0016079) | 2.43478789 |
| 105 | proline transport (GO:0015824) | 2.42651316 |
| 106 | adenosine receptor signaling pathway (GO:0001973) | 2.42067232 |
| 107 | glycolipid catabolic process (GO:0019377) | 2.41229553 |
| 108 | myeloid dendritic cell differentiation (GO:0043011) | 2.40507725 |
| 109 | negative regulation of granulocyte differentiation (GO:0030853) | 2.39690974 |
| 110 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.39562180 |
| 111 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.39227050 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.38706142 |
| 113 | signal complex assembly (GO:0007172) | 2.38641021 |
| 114 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38547982 |
| 115 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.37837747 |
| 116 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.37546540 |
| 117 | myeloid leukocyte activation (GO:0002274) | 2.37353667 |
| 118 | neutrophil migration (GO:1990266) | 2.37347978 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.37074412 |
| 120 | lipoprotein transport (GO:0042953) | 2.36531129 |
| 121 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.36439481 |
| 122 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.36368420 |
| 123 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.36013481 |
| 124 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.35950817 |
| 125 | clathrin coat assembly (GO:0048268) | 2.35362926 |
| 126 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.33053489 |
| 127 | regulation of ARF GTPase activity (GO:0032312) | 2.32616232 |
| 128 | cellular extravasation (GO:0045123) | 2.32027065 |
| 129 | glycosphingolipid catabolic process (GO:0046479) | 2.30649134 |
| 130 | pinocytosis (GO:0006907) | 2.29472989 |
| 131 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.28966997 |
| 132 | phagocytosis (GO:0006909) | 2.28209087 |
| 133 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.26348078 |
| 134 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.26155036 |
| 135 | synaptic vesicle endocytosis (GO:0048488) | 2.22353739 |
| 136 | regulation of cholesterol storage (GO:0010885) | 2.22294109 |
| 137 | regulation of mononuclear cell migration (GO:0071675) | 2.21205805 |
| 138 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.20814945 |
| 139 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.20785480 |
| 140 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.20322122 |
| 141 | positive regulation of phagocytosis (GO:0050766) | 2.19543914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.67974500 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.99766449 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.60060660 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50097497 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.32680825 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.27905470 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80620142 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.39840199 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34342774 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.25887987 |
| 11 | SPI1_23127762_ChIP-Seq_K562_Human | 2.25361430 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.24322465 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19463722 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17051675 |
| 15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93806279 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89199957 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86077270 |
| 18 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.80122590 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77198766 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67673356 |
| 21 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.66076852 |
| 22 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.63485662 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.61651426 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60466085 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57717132 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.54690251 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54400414 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52138175 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51520975 |
| 30 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51418424 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47774720 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47098908 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46305161 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45072375 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42462689 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42038667 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41351233 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.41169906 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40886999 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.38078087 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36266270 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34203491 |
| 43 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31653006 |
| 44 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.31633118 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31458414 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.31101093 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29298904 |
| 48 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.28968320 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27991452 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26675852 |
| 51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25510396 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.24255229 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23636391 |
| 54 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.22406492 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20683661 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19932580 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19834632 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19750482 |
| 59 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.18489465 |
| 60 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17769118 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17235559 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16758063 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14004833 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12169578 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.12051533 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11316368 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10460968 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09012754 |
| 69 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08484306 |
| 70 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08435967 |
| 71 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08295233 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06732628 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06414951 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05894880 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04925726 |
| 76 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.03595129 |
| 77 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.03595129 |
| 78 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.03591179 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.03347370 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03338311 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03076077 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02591574 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02346270 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02270952 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01928535 |
| 86 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.01784475 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01680954 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01037411 |
| 89 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99406879 |
| 90 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99044548 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98997932 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98843117 |
| 93 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.96671571 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96579996 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96366043 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96068406 |
| 97 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95278494 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95065306 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94959440 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94739498 |
| 101 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94668453 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93368007 |
| 103 | MYC_22102868_ChIP-Seq_BL_Human | 0.92861775 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91350947 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91172462 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 0.91087913 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89262491 |
| 108 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.88232274 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87989607 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87989607 |
| 111 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86554403 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86465783 |
| 113 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86200644 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.85991006 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85977873 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85888185 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85845161 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85092759 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85015004 |
| 120 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.84802987 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84776071 |
| 122 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84653865 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84439541 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84166096 |
| 125 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83974102 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81182802 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79130503 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79125006 |
| 129 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78913576 |
| 130 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78879549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.98981325 |
| 2 | MP0003172_abnormal_lysosome_physiology | 4.40320554 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.07720972 |
| 4 | MP0003303_peritoneal_inflammation | 3.73483324 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.53874273 |
| 6 | MP0003690_abnormal_glial_cell | 2.84707760 |
| 7 | MP0006082_CNS_inflammation | 2.80688492 |
| 8 | MP0004510_myositis | 2.76967165 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.76730375 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.67834863 |
| 11 | MP0003436_decreased_susceptibility_to | 2.51226779 |
| 12 | * MP0002419_abnormal_innate_immunity | 2.50716719 |
| 13 | MP0003075_altered_response_to | 2.46102144 |
| 14 | MP0000604_amyloidosis | 2.43903257 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.34722183 |
| 16 | MP0009840_abnormal_foam_cell | 2.14225671 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.10782003 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.03224619 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.99298831 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.96406003 |
| 21 | MP0004858_abnormal_nervous_system | 1.86152484 |
| 22 | MP0008260_abnormal_autophagy | 1.84416883 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.78647324 |
| 24 | MP0002064_seizures | 1.76321221 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.74420649 |
| 26 | MP0009046_muscle_twitch | 1.72413699 |
| 27 | * MP0002452_abnormal_antigen_presenting | 1.68939560 |
| 28 | MP0001790_abnormal_immune_system | 1.60767620 |
| 29 | MP0005387_immune_system_phenotype | 1.60767620 |
| 30 | MP0005025_abnormal_response_to | 1.59726687 |
| 31 | MP0009278_abnormal_bone_marrow | 1.59515869 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.54820419 |
| 33 | MP0002090_abnormal_vision | 1.53419362 |
| 34 | MP0005310_abnormal_salivary_gland | 1.52069726 |
| 35 | MP0002723_abnormal_immune_serum | 1.51428323 |
| 36 | MP0005166_decreased_susceptibility_to | 1.50621183 |
| 37 | MP0003828_pulmonary_edema | 1.49871012 |
| 38 | MP0005451_abnormal_body_composition | 1.49849113 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.49146891 |
| 40 | MP0003633_abnormal_nervous_system | 1.44173789 |
| 41 | MP0001800_abnormal_humoral_immune | 1.39203597 |
| 42 | MP0009785_altered_susceptibility_to | 1.37809384 |
| 43 | * MP0001819_abnormal_immune_cell | 1.34380079 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.32576555 |
| 45 | * MP0002420_abnormal_adaptive_immunity | 1.31992562 |
| 46 | MP0003634_abnormal_glial_cell | 1.30824746 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.30149997 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.29873794 |
| 49 | MP0009745_abnormal_behavioral_response | 1.29435586 |
| 50 | MP0000343_altered_response_to | 1.29084066 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.28753922 |
| 52 | MP0005671_abnormal_response_to | 1.27479316 |
| 53 | MP0003329_amyloid_beta_deposits | 1.25768200 |
| 54 | MP0000858_altered_metastatic_potential | 1.21753522 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.19849154 |
| 56 | MP0003279_aneurysm | 1.19729519 |
| 57 | MP0000920_abnormal_myelination | 1.18781586 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.18304470 |
| 59 | MP0002909_abnormal_adrenal_gland | 1.18001577 |
| 60 | MP0001851_eye_inflammation | 1.16548390 |
| 61 | MP0008004_abnormal_stomach_pH | 1.15579464 |
| 62 | MP0004947_skin_inflammation | 1.14778332 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.12924086 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.11839898 |
| 65 | MP0000685_abnormal_immune_system | 1.10330969 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.10233047 |
| 67 | MP0003448_altered_tumor_morphology | 1.09502604 |
| 68 | MP0004270_analgesia | 1.06091577 |
| 69 | MP0008469_abnormal_protein_level | 1.03279695 |
| 70 | MP0001958_emphysema | 1.01434147 |
| 71 | MP0002405_respiratory_system_inflammati | 1.01191746 |
| 72 | MP0003880_abnormal_central_pattern | 1.00675479 |
| 73 | MP0003631_nervous_system_phenotype | 0.97532812 |
| 74 | MP0003724_increased_susceptibility_to | 0.97038039 |
| 75 | MP0004130_abnormal_muscle_cell | 0.96880971 |
| 76 | MP0008569_lethality_at_weaning | 0.96575068 |
| 77 | MP0001968_abnormal_touch/_nociception | 0.96306972 |
| 78 | MP0002254_reproductive_system_inflammat | 0.95780770 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.94637418 |
| 80 | MP0005390_skeleton_phenotype | 0.93102282 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.93009760 |
| 82 | MP0010307_abnormal_tumor_latency | 0.92402539 |
| 83 | MP0003045_fibrosis | 0.92109854 |
| 84 | MP0001440_abnormal_grooming_behavior | 0.90257915 |
| 85 | MP0002736_abnormal_nociception_after | 0.89099940 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 0.88976831 |
| 87 | MP0001849_ear_inflammation | 0.88322682 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.85981301 |
| 89 | MP0001486_abnormal_startle_reflex | 0.84493595 |
| 90 | MP0000371_diluted_coat_color | 0.83045228 |
| 91 | MP0001853_heart_inflammation | 0.82523797 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.80614810 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.80039491 |
| 94 | * MP0002398_abnormal_bone_marrow | 0.79975427 |
| 95 | * MP0000716_abnormal_immune_system | 0.79622398 |
| 96 | MP0009764_decreased_sensitivity_to | 0.79485145 |
| 97 | MP0001970_abnormal_pain_threshold | 0.79383779 |
| 98 | MP0002139_abnormal_hepatobiliary_system | 0.79305150 |
| 99 | MP0003879_abnormal_hair_cell | 0.78365978 |
| 100 | MP0003091_abnormal_cell_migration | 0.75753380 |
| 101 | MP0002733_abnormal_thermal_nociception | 0.75683999 |
| 102 | MP0004811_abnormal_neuron_physiology | 0.75517592 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.75390955 |
| 104 | MP0005023_abnormal_wound_healing | 0.74535069 |
| 105 | MP0005165_increased_susceptibility_to | 0.74179367 |
| 106 | MP0005164_abnormal_response_to | 0.73530511 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.73014252 |
| 108 | MP0008874_decreased_physiological_sensi | 0.72861135 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.72562209 |
| 110 | MP0005388_respiratory_system_phenotype | 0.72233208 |
| 111 | MP0002133_abnormal_respiratory_system | 0.72233208 |
| 112 | MP0002067_abnormal_sensory_capabilities | 0.72059468 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.71846065 |
| 114 | MP0003632_abnormal_nervous_system | 0.71779975 |
| 115 | MP0006054_spinal_hemorrhage | 0.71767827 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.71616046 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.70676441 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.70676441 |
| 119 | MP0004883_abnormal_blood_vessel | 0.70237679 |
| 120 | * MP0002429_abnormal_blood_cell | 0.70159771 |
| 121 | MP0003795_abnormal_bone_structure | 0.69906396 |
| 122 | MP0005409_darkened_coat_color | 0.68587134 |
| 123 | MP0005535_abnormal_body_temperature | 0.67703244 |
| 124 | MP0000249_abnormal_blood_vessel | 0.67594436 |
| 125 | MP0003705_abnormal_hypodermis_morpholog | 0.66650212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 6.44806692 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.53353842 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.37877536 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.37877536 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.37877536 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.33354276 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.04471138 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.93837217 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.85349197 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.49892919 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.46240743 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.12073284 |
| 13 | Mucopolysacchariduria (HP:0008155) | 4.00543350 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.00543350 |
| 15 | Disinhibition (HP:0000734) | 3.96482675 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.92797050 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.92797050 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.92797050 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.90383996 |
| 20 | Glomerulonephritis (HP:0000099) | 3.78628156 |
| 21 | Mutism (HP:0002300) | 3.76994062 |
| 22 | Axonal loss (HP:0003447) | 3.63036360 |
| 23 | Neuronal loss in central nervous system (HP:0002529) | 3.47073630 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.40672401 |
| 25 | Loss of speech (HP:0002371) | 3.26724043 |
| 26 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.11930282 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07384823 |
| 28 | Gingivitis (HP:0000230) | 3.00129481 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 2.98073380 |
| 30 | Retinal atrophy (HP:0001105) | 2.96180395 |
| 31 | Apathy (HP:0000741) | 2.87491130 |
| 32 | Neurofibrillary tangles (HP:0002185) | 2.86994376 |
| 33 | Inappropriate behavior (HP:0000719) | 2.82257124 |
| 34 | Recurrent skin infections (HP:0001581) | 2.78048840 |
| 35 | J-shaped sella turcica (HP:0002680) | 2.77798980 |
| 36 | Abnormality of binocular vision (HP:0011514) | 2.74776929 |
| 37 | Diplopia (HP:0000651) | 2.74776929 |
| 38 | Diminished motivation (HP:0000745) | 2.73322195 |
| 39 | Global brain atrophy (HP:0002283) | 2.69868373 |
| 40 | Hematochezia (HP:0002573) | 2.69827347 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.67250509 |
| 42 | Upper motor neuron abnormality (HP:0002127) | 2.59701774 |
| 43 | Agnosia (HP:0010524) | 2.58920464 |
| 44 | Obstructive lung disease (HP:0006536) | 2.49550327 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.49550327 |
| 46 | Stomatitis (HP:0010280) | 2.48750448 |
| 47 | Focal motor seizures (HP:0011153) | 2.47392656 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.45436034 |
| 49 | Visual hallucinations (HP:0002367) | 2.41441359 |
| 50 | Amyloidosis (HP:0011034) | 2.41112075 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.38515121 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.36904063 |
| 53 | Arterial tortuosity (HP:0005116) | 2.35788599 |
| 54 | Purpura (HP:0000979) | 2.35735802 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.35359619 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.32478086 |
| 57 | Papilledema (HP:0001085) | 2.29180119 |
| 58 | Complement deficiency (HP:0004431) | 2.29158532 |
| 59 | Postural instability (HP:0002172) | 2.28397334 |
| 60 | Focal seizures (HP:0007359) | 2.26579843 |
| 61 | Nuclear cataract (HP:0100018) | 2.25598849 |
| 62 | Dementia (HP:0000726) | 2.23133379 |
| 63 | Nephritis (HP:0000123) | 2.22421092 |
| 64 | Increased CSF protein (HP:0002922) | 2.21768750 |
| 65 | Myositis (HP:0100614) | 2.19108572 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.16814158 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.16140332 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16017806 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.14960975 |
| 70 | Obstructive sleep apnea (HP:0002870) | 2.14544739 |
| 71 | Action tremor (HP:0002345) | 2.13911470 |
| 72 | Hemoptysis (HP:0002105) | 2.13566065 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.12001821 |
| 74 | Clumsiness (HP:0002312) | 2.11720682 |
| 75 | Meningitis (HP:0001287) | 2.10439240 |
| 76 | Abnormality of the periventricular white matter (HP:0002518) | 2.09564113 |
| 77 | Periodontitis (HP:0000704) | 2.09482995 |
| 78 | Increased IgE level (HP:0003212) | 2.09139411 |
| 79 | Thoracic kyphosis (HP:0002942) | 2.07388663 |
| 80 | Pathologic fracture (HP:0002756) | 2.07141738 |
| 81 | Memory impairment (HP:0002354) | 2.06798039 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.05087601 |
| 83 | Progressive visual loss (HP:0000529) | 2.04528734 |
| 84 | Thick nail (HP:0001805) | 2.04090716 |
| 85 | Vasculitis (HP:0002633) | 2.03993050 |
| 86 | Myocardial infarction (HP:0001658) | 2.03227472 |
| 87 | Orchitis (HP:0100796) | 2.02325658 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01743291 |
| 89 | Vascular tortuosity (HP:0004948) | 2.01570911 |
| 90 | Basal ganglia calcification (HP:0002135) | 2.01524492 |
| 91 | Abnormality of complement system (HP:0005339) | 2.00195168 |
| 92 | Peripheral demyelination (HP:0011096) | 1.98281829 |
| 93 | Episodic fever (HP:0001954) | 1.97850646 |
| 94 | Cellulitis (HP:0100658) | 1.97776355 |
| 95 | Colitis (HP:0002583) | 1.97539169 |
| 96 | Peripheral hypomyelination (HP:0007182) | 1.96733960 |
| 97 | Hepatosplenomegaly (HP:0001433) | 1.96661319 |
| 98 | Progressive neurologic deterioration (HP:0002344) | 1.96031814 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 1.93410865 |
| 100 | Hemiplegia (HP:0002301) | 1.92395253 |
| 101 | Ankle clonus (HP:0011448) | 1.91939803 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 1.90721178 |
| 103 | Myokymia (HP:0002411) | 1.89729233 |
| 104 | Urethral obstruction (HP:0000796) | 1.88790599 |
| 105 | Peritonitis (HP:0002586) | 1.87501786 |
| 106 | Deformed sella turcica (HP:0002681) | 1.85332939 |
| 107 | Pulmonary embolism (HP:0002204) | 1.82154905 |
| 108 | Petechiae (HP:0000967) | 1.80931638 |
| 109 | Prostate neoplasm (HP:0100787) | 1.80914761 |
| 110 | Increased serum ferritin (HP:0003281) | 1.80511180 |
| 111 | Frequent falls (HP:0002359) | 1.80430741 |
| 112 | Vertigo (HP:0002321) | 1.80362961 |
| 113 | Vertebral compression fractures (HP:0002953) | 1.80085514 |
| 114 | Ocular albinism (HP:0001107) | 1.80007194 |
| 115 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.79412471 |
| 116 | Recurrent cutaneous fungal infections (HP:0011370) | 1.79412471 |
| 117 | Neurodegeneration (HP:0002180) | 1.79234234 |
| 118 | Gingival bleeding (HP:0000225) | 1.78799395 |
| 119 | Rapidly progressive (HP:0003678) | 1.78131747 |
| 120 | Premature loss of primary teeth (HP:0006323) | 1.77807530 |
| 121 | Striae distensae (HP:0001065) | 1.77580015 |
| 122 | Personality changes (HP:0000751) | 1.76985314 |
| 123 | Bone pain (HP:0002653) | 1.75762530 |
| 124 | Polygenic inheritance (HP:0010982) | 1.74897211 |
| 125 | Absent frontal sinuses (HP:0002688) | 1.74004165 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.72884501 |
| 127 | Generalized tonic-clonic seizures (HP:0002069) | 1.71983194 |
| 128 | Urticaria (HP:0001025) | 1.71683903 |
| 129 | Optic neuritis (HP:0100653) | 1.70996543 |
| 130 | Retrobulbar optic neuritis (HP:0100654) | 1.70996543 |
| 131 | Spondylolisthesis (HP:0003302) | 1.70882610 |
| 132 | Abnormality of the thoracic spine (HP:0100711) | 1.68025823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.11813343 |
| 2 | MAP3K9 | 2.69340098 |
| 3 | TGFBR2 | 2.64814055 |
| 4 | FES | 2.44045052 |
| 5 | DAPK2 | 2.38098656 |
| 6 | MAP3K13 | 2.31939990 |
| 7 | EPHA4 | 2.25335439 |
| 8 | CAMKK1 | 2.14437945 |
| 9 | BLK | 2.07412963 |
| 10 | TYK2 | 2.00620092 |
| 11 | CAMKK2 | 2.00530946 |
| 12 | CAMK1G | 1.94660715 |
| 13 | MAP3K11 | 1.92239474 |
| 14 | CAMK1D | 1.92104428 |
| 15 | KIT | 1.92015595 |
| 16 | TBK1 | 1.86934016 |
| 17 | SIK2 | 1.86695848 |
| 18 | KSR2 | 1.85228521 |
| 19 | NTRK3 | 1.78208204 |
| 20 | CSF1R | 1.77201468 |
| 21 | IRAK4 | 1.73096293 |
| 22 | MAP3K3 | 1.70606259 |
| 23 | IRAK3 | 1.63915335 |
| 24 | RIPK1 | 1.63335152 |
| 25 | FGR | 1.62858310 |
| 26 | TRIB3 | 1.62131942 |
| 27 | TAOK2 | 1.56656698 |
| 28 | JAK1 | 1.55954941 |
| 29 | MAP3K14 | 1.55234529 |
| 30 | ERN1 | 1.54436997 |
| 31 | DDR2 | 1.48191581 |
| 32 | HCK | 1.35915267 |
| 33 | PAK6 | 1.31884917 |
| 34 | SCYL2 | 1.28746953 |
| 35 | MAP4K1 | 1.24439942 |
| 36 | CDC42BPA | 1.23183400 |
| 37 | TAOK3 | 1.15097455 |
| 38 | DAPK1 | 1.14055874 |
| 39 | GRK7 | 1.13374367 |
| 40 | MARK2 | 1.13153701 |
| 41 | MAP3K2 | 1.10704586 |
| 42 | NTRK1 | 1.08696370 |
| 43 | SYK | 1.03619079 |
| 44 | PDK1 | 1.00220495 |
| 45 | MINK1 | 1.00134168 |
| 46 | CSK | 0.99468706 |
| 47 | PDPK1 | 0.98100744 |
| 48 | PRKCH | 0.97335140 |
| 49 | PRKD3 | 0.96279533 |
| 50 | SGK3 | 0.92896522 |
| 51 | IKBKE | 0.91209259 |
| 52 | IRAK2 | 0.90447938 |
| 53 | PKN2 | 0.90262706 |
| 54 | ARAF | 0.88737488 |
| 55 | MATK | 0.87983012 |
| 56 | PLK2 | 0.85801795 |
| 57 | PTK6 | 0.84540409 |
| 58 | CDK5 | 0.82181148 |
| 59 | NTRK2 | 0.81772366 |
| 60 | TYRO3 | 0.79421590 |
| 61 | PTK2B | 0.78963685 |
| 62 | MOS | 0.77692894 |
| 63 | FYN | 0.77322203 |
| 64 | GRK5 | 0.77289975 |
| 65 | STK38 | 0.75744718 |
| 66 | PRKD2 | 0.74896003 |
| 67 | MAP3K4 | 0.72952194 |
| 68 | LYN | 0.72895987 |
| 69 | ZAP70 | 0.72840635 |
| 70 | MAP3K1 | 0.71917669 |
| 71 | TTN | 0.71231475 |
| 72 | MAP2K3 | 0.70307426 |
| 73 | EGFR | 0.69635812 |
| 74 | RET | 0.69333743 |
| 75 | PAK4 | 0.68865410 |
| 76 | CLK1 | 0.68452150 |
| 77 | LATS2 | 0.67768038 |
| 78 | IKBKB | 0.67413292 |
| 79 | UHMK1 | 0.67144631 |
| 80 | EPHB1 | 0.67076274 |
| 81 | MAPK12 | 0.66762961 |
| 82 | SGK2 | 0.66101260 |
| 83 | MAP2K4 | 0.66024200 |
| 84 | ALK | 0.65187365 |
| 85 | PRPF4B | 0.65149066 |
| 86 | LCK | 0.65086809 |
| 87 | * JAK2 | 0.64774177 |
| 88 | TAOK1 | 0.64225766 |
| 89 | DMPK | 0.63256777 |
| 90 | PRKG2 | 0.63244999 |
| 91 | CAMK4 | 0.62929193 |
| 92 | GRK6 | 0.61940421 |
| 93 | PDGFRA | 0.61705630 |
| 94 | SIK3 | 0.61246955 |
| 95 | MAPK15 | 0.60560612 |
| 96 | BTK | 0.59326162 |
| 97 | BMPR2 | 0.58321344 |
| 98 | SGK1 | 0.57491424 |
| 99 | BMX | 0.56949570 |
| 100 | MAP3K5 | 0.56126244 |
| 101 | SIK1 | 0.55819838 |
| 102 | TESK1 | 0.52518480 |
| 103 | ABL2 | 0.52027805 |
| 104 | TXK | 0.51368986 |
| 105 | NME2 | 0.50201010 |
| 106 | JAK3 | 0.48111551 |
| 107 | MAP3K6 | 0.47154877 |
| 108 | CAMK1 | 0.46722208 |
| 109 | RPS6KA2 | 0.46646015 |
| 110 | STK11 | 0.46025172 |
| 111 | MAP2K6 | 0.45385375 |
| 112 | PRKCD | 0.45244438 |
| 113 | TESK2 | 0.44143661 |
| 114 | MAPK4 | 0.44135013 |
| 115 | SRC | 0.42594416 |
| 116 | PDGFRB | 0.42351092 |
| 117 | MAPK7 | 0.41630461 |
| 118 | TNK2 | 0.40093859 |
| 119 | KSR1 | 0.39588411 |
| 120 | ABL1 | 0.39075978 |
| 121 | MARK3 | 0.37916683 |
| 122 | PRKCG | 0.37762928 |
| 123 | SGK223 | 0.37528965 |
| 124 | SGK494 | 0.37528965 |
| 125 | RAF1 | 0.34917091 |
| 126 | DAPK3 | 0.33868344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.86238560 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.70641514 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33839337 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.07024179 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.02952077 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95632194 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93369678 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.89213622 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 1.76093863 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66979912 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.65996442 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64002350 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57456055 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.55672667 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.49923282 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45782650 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.37997215 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36720182 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.35888245 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33782712 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33750952 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30051703 |
| 23 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.21388570 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.19591914 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17509256 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16609565 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16480906 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15415744 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.15209084 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.15155564 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.15028449 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12105815 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11235170 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11066301 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10891915 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.09262620 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.08011084 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07210346 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07096242 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06149149 |
| 41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.05838787 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.05047207 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.04083070 |
| 44 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98633713 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97505314 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.97481057 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97065375 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96967957 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.96701692 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.96407144 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94019987 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93186018 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92821506 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92657866 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.91537016 |
| 56 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89517982 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88214672 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87918242 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.87497148 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86895648 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.86315493 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85971100 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85904612 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85416358 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83190237 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.81390123 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81300046 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81295269 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.81263227 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.80862768 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.80418695 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79743486 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79568042 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.79380405 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.78827043 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78653498 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77436081 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76191770 |
| 79 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74709150 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71785408 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71729167 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70891926 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70380258 |
| 84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70364156 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70309274 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70210772 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70078107 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69960990 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69700812 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68985851 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68902186 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.68373848 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67287989 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66946606 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.66935726 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65649775 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.65635521 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64879720 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63713317 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61728781 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.60877769 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60571337 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60375068 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60042788 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58333510 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58201219 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58111221 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57857384 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57829168 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57412670 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57188474 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55846557 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.54877335 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54802475 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52915565 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51824789 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51602695 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51169332 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51077500 |

